The role of bevacizumab in solid tumours: A literature based meta-analysis of randomised trials.
about
Repurposing itraconazole as an anticancer agent.Ramucirumab in the treatment of non-small cell lung cancer.MicroRNAs as a tool to aid stratification of colorectal cancer patients and to guide therapy.Integrins as Therapeutic Targets: Successes and Cancers.Bevacizumab in small cell lung cancer.Long non-coding RNAs associated with non-small cell lung cancer.Therapeutic strategies against cancer stem cells in human colorectal cancer.New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.Evaluation of efficacy and safety for bevacizumab in treating malignant pleural effusions caused by lung cancer through intrapleural injection.Could gonadotropin-releasing hormone analogs be helpful in the treatment of triple-negative breast cancer?Bevacizumab-associated Bowel Microperforation in a Patient With Neuroblastoma.Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancer.Machine Learning and Radiogenomics: Lessons Learned and Future Directions.Targeted Intracellular Delivery of Antibodies: The State of the ArtRecurrent colon perforation after discontinuation of bevacizumab for ovarian cancerCurcumin analog, GO-Y078, overcomes resistance to tumor angiogenesis inhibitorsEffects of Two-by-Two Combination Therapy with Valproic Acid, Lithium Chloride, and Celecoxib on the Angiogenesis of the Chicken Chorioallantoic Membrane
P2860
Q38633691-905579C2-3ADD-49D3-8246-F54442072B35Q39232340-EA437AE3-FA1D-4962-B84E-3A784735B752Q39390383-45F9C79A-D1B2-4B7A-B2F8-BFE4351FDEF1Q41670949-391CD536-4160-4CDC-9FBD-5333A4875059Q42359058-D59C2A73-EBAD-45F0-8D77-535CE1F336C7Q42366666-58CA8D96-2A0C-40A9-A82E-B384E2DAD37DQ47149854-965E2691-5B1E-4180-8FBA-86486E681B8CQ47221234-3DB4457A-A8F9-4C0E-9635-5B67034FC6B2Q47646891-554D929A-5CDA-422A-BC18-23C30BC044CEQ47848539-21890F40-1BBD-4F7B-93FC-2C5F1A9977ADQ53735971-1159E51C-6AFB-4A0C-A353-EFB66A2F053FQ55037961-287E15FA-120F-41C2-B3AB-663F65ECF4AFQ55428338-1232A999-450B-452E-8AF5-FD5F18652380Q58566968-10C1849D-3E34-448C-BE56-597D8B50AC51Q58705919-E8B7C5DE-672B-40EB-A927-DDFD5675C694Q58772394-BE7BE54D-2383-42AB-9323-CFF2795C0D3CQ58776363-7EBF61B1-4721-47AA-ABED-F2D3EAD1AF8D
P2860
The role of bevacizumab in solid tumours: A literature based meta-analysis of randomised trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The role of bevacizumab in sol ...... analysis of randomised trials.
@en
The role of bevacizumab in sol ...... analysis of randomised trials.
@nl
type
label
The role of bevacizumab in sol ...... analysis of randomised trials.
@en
The role of bevacizumab in sol ...... analysis of randomised trials.
@nl
prefLabel
The role of bevacizumab in sol ...... analysis of randomised trials.
@en
The role of bevacizumab in sol ...... analysis of randomised trials.
@nl
P2093
P1476
The role of bevacizumab in sol ...... -analysis of randomised trials
@en
P2093
Andrew R Reynolds
Clifford A Hudis
Daniele Generali
Roberto Petrioli
Thomas Bachelot
P304
P356
10.1016/J.EJCA.2017.01.026
P577
2017-02-24T00:00:00Z